NOVEL SODIUM CHANNEL BLOCKING PEPTIDES AND THE USE THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15649922

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to C-terminal modified Protoxin II peptides that selectively inhibit the Nav1.7 sodium channel; the present invention also relates to pharmaceutical compositions useful for prophylactic or therapeutic treatment of a disorder responsive to the blockade of sodium ion channels, especially Nav1.7 sodium ion channels; the present invention further provides methods of treating a disorder responsive to the blockade of sodium channels, and particularly Nav1.7 sodium channels, in a mammal sulfuring from excess activity of said channels.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PURDUE PHARMA L PONE STAMFORD FORUM 201 TRESSER BOULEVARD STAMFORD CT 06901

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kyle, Donald James Yardley, US 9 23
Park, Jae Hyun Chandler, US 322 1977

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation